PDUFA dates August 2023: FDA calendar and catalysts.
1 PDUFA date fell in August 2023: MVASI® (August 29). The FDA calendar also recorded 28 other catalysts that month, such as advisory committees and readouts, each quoted from the sponsor’s SEC filing or the FDA.
PDUFA dates in August 2023
| PDUFA date | Company | Ticker | Drug | Indication | Source |
|---|---|---|---|---|---|
| August 29, 2023 | Outlook Therapeutics, Inc. | OTLK | MVASI® (bevacizumab) | SEC 8-K Exhibit 99.1, filed 2026-03-16 |
Download: CSV · JSON · iCal (next 30 days, CC BY 4.0) · Calendar API · All months
August 2023: other FDA decisions and filings
August 2023: dated readouts
| Date | Drug | Company | Event | Indication | Status | Source |
|---|---|---|---|---|---|---|
| Aug 2023Month disclosed | CABOMETYX® (cabozantinib) | EXEL | Topline readout | measurable, extra-pelvic metastatic castration-resistant prostate cancer | Positive | SEC Form 10-Q |
| Aug 2023Month disclosed | Hummingbird | NVAX | Topline readout | — | Met primary endpoint | SEC Form 10-Q |
August 2023: trial starts and primary completions
| Date | Drug | Company | Event | Indication | Status | Source |
|---|---|---|---|---|---|---|
| Aug 2023Month disclosed | zipalertinib (CLN-081) | CGEM | Trial start | — | Completed | SEC Form 10-K |
| Aug 2023Month disclosed | neflamapimod | CRVO | Trial start | DLB funded primarily | Completed | SEC Form 10-K |
| Aug 2023Month disclosed | TTI-101 | TVRD | Trial start | suffering | Completed | sec_s1 |
| Aug 2023Month disclosed | BOS-342 | PVLA | Trial start | — | Completed | sec_s1 |
| Aug 2023Month disclosed | TRUXIMA® (rituximab) | ARTV | Trial start | class III or IV LN in August 2023 | Completed | SEC Form 10-K |
Questions
What PDUFA dates are in August 2023?
1 PDUFA date fell in August 2023: MVASI® (August 29). The FDA calendar also recorded 28 other catalysts that month, such as advisory committees and readouts, each quoted from the sponsor’s SEC filing or the FDA.
Can these dates change?
Yes. The FDA can extend a review by three months after a major amendment, and it sometimes acts before the goal date. Each row links the filing the date came from.
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.